News tagged with pharmaceutical industry

Adverse prognostic factor ID'd in operable breast cancer

(HealthDay)—For women with operable breast cancer, moderate immunohistochemical expression of human epidermal growth factor receptor (HER)-2 (2+) without amplification of HER-2 (HER-2 2+/HER-2−) is an adverse prognostic ...

Oct 30, 2012
popularity not rated yet | comments 0

Unsuspected PE seldom linked to death in cancer patients

(HealthDay)—Unsuspected pulmonary embolism (UPE) is not associated with an increased risk of death in cancer patients when compared to patients without pulmonary embolism (PE), according to research published ...

Oct 09, 2012
popularity not rated yet | comments 0

Patient preference doesn't affect chemo in advanced CRC

(HealthDay)—For patients with metastatic colorectal cancer (mCRC), most patients are treated with chemotherapy, even if they express negative or marginal preferences, according to a study published online ...

Sep 21, 2012
popularity not rated yet | comments 0

Can disclosure hurt the translation of research?

All major clinical trials now include disclosures detailing who funded the study to ensure transparency. However, is it possible that this transparency is actually hurting research? One might assume that the methodological ...

Sep 19, 2012
popularity not rated yet | comments 0 | with audio podcast

10 drugmakers team up to improve testing process

(AP)—Pharmaceutical industry heavyweights are teaming up to address a challenge that's long vexed drugmakers: how to improve the way experimental drugs are tested so they can get approved, and reach patients, faster.

Sep 19, 2012
popularity not rated yet | comments 0

Prolonged dexamethasone cuts delayed nausea after chemo

(HealthDay) -- Adding dexamethasone to prochlorperazine on days two and three, following palonosetron and dexamethasone on day one, reduces delayed nausea (DN) in patients receiving chemotherapy containing ...

Aug 22, 2012
popularity not rated yet | comments 0